For media inquiries
Media@OriBiotech.com
Discover how we're driving innovation in cell & gene manufacturing.
We’re on a mission to enable patient access to life saving treatments—find out more about how we are fully automating and standardizing CGT manufacturing to solve complex manufacturing challenges.
News & events
Continuous manufacturing builds on hype but adoption remains gradualwww.pharmaceutical-technology.com
www.pharmaceutical-technology.com
Automation, standardisation hold potential for overcoming CGT manufacturing challenges
www.scienceboard.net
“No, one size does not fit all.” David Smith, Vice President of Technical Operations, discusses gene therapy manufacturing
www.themedicinemaker.com
Matt Todd, Head of Architecture at Oribiotech on automation and digital manufacturing for cell and gene therapies – why paper is the enemy of scale
www.technologynetworks.com
The quest to take cell therapy beyond cancer
www.criver.com
Ori Biotech addressing issues in patients accessing advanced cell and gene therapies
www.vjregenmed.com
Ori Biotech discusses why paper is the enemy of scale in CGT manufacturing
www.bioprocessintl.com
Envisioning the cost-effective future of cell and gene therapy manufacturing
www.phacilitate.com
Regulatory challenges and success in Series B: an interview with Jason C. Foster
www.regmednet.com
Ori Biotech reaps $100M in series B round to help launch innovative cell manufacturing tech
https://www.fiercepharma.com
UK upstart raises $100M in bid to digitize and standardize cell and gene therapy manufacturing
https://endpts.com
Ori Biotech Discusses Advanced Therapy Biomanufacturing as a Service
genengnews.com